RANKL/OPG in Breast Cancer — Extending Its Territory to BRCA Mutation Carriers

por Rachner, Tilman D., Rauner, Martina
Publicado 2015

Prospects of adjuvant RANKL inhibition in breast cancer?

por Rachner, T D, Wimberger, P, Hofbauer, L C
Publicado 2015

From bone to breast and back - the bone cytokine RANKL and breast cancer

por Hofbauer, Lorenz C, Rachner, Tilman D, Hamann, Christine
Publicado 2011

Targeting Bone Metabolism in Patients with Advanced Prostate Cancer: Current Options and Controversies

por Todenhöfer, Tilman, Stenzl, Arnulf, Hofbauer, Lorenz C., Rachner, Tilman D.
Publicado 2015

Induction of 3-hydroxy-3-methylglutaryl-CoA reductase mediates statin resistance in breast cancer cells

por Göbel, Andy, Breining, Dorit, Rauner, Martina, Hofbauer, Lorenz C., Rachner, Tilman D.
Publicado 2019

Skeletal endocrinology: where evolutionary advantage meets disease

por Jaschke, Nikolai, Sipos, Wolfgang, Hofbauer, Lorenz C., Rachner, Tilman D., Rauner, Martina
Publicado 2021

p38 MAPK regulates the Wnt inhibitor Dickkopf-1 in osteotropic prostate cancer cells

por Browne, A J, Göbel, A, Thiele, S, Hofbauer, L C, Rauner, M, Rachner, T D
Publicado 2016

Targeting syndecan-1 in breast cancer inhibits osteoclast functions through up-regulation of osteoprotegerin

por Benad-Mehner, Peggy, Thiele, Stefanie, Rachner, Tilman D., Göbel, Andy, Rauner, Martina, Hofbauer, Lorenz C.
Publicado 2013

Mice lacking DKK1 in T cells exhibit high bone mass and are protected from estrogen-deficiency-induced bone loss

por Lehmann, Juliane, Thiele, Sylvia, Baschant, Ulrike, Rachner, Tilman D., Niehrs, Christof, Hofbauer, Lorenz C., Rauner, Martina
Publicado 2021

Regulation of VEGF by mevalonate pathway inhibition in breast cancer

por Rachner, Tilman D., Göbel, Andy, Junker, Maria, Hötzel, Josefa, Benad-Mehner, Peggy, Hadji, Peyman, Hofbauer, Lorenz C.
Publicado 2013

The Role of Inflammation in Breast and Prostate Cancer Metastasis to Bone

por Göbel, Andy, Dell’Endice, Stefania, Jaschke, Nikolai, Pählig, Sophie, Shahid, Amna, Hofbauer, Lorenz C., Rachner, Tilman D.
Publicado 2021

Anti-tumor effects of mevalonate pathway inhibition in ovarian cancer

por Göbel, Andy, Zinna, Valentina M., Dell’Endice, Stefania, Jaschke, Nikolai, Kuhlmann, Jan Dominik, Wimberger, Pauline, Rachner, Tilman D.
Publicado 2020

Clinical impact of soluble Neuropilin-1 in ovarian cancer patients and its association with its circulating ligands of the HGF/c-MET axis

por Klotz, Daniel Martin, Kuhlmann, Jan Dominik, Link, Theresa, Goeckenjan, Maren, Hofbauer, Lorenz C., Göbel, Andy, Rachner, Tilman D., Wimberger, Pauline
Publicado 2022

Zoledronic acid and atorvastatin inhibit αvβ3-mediated adhesion of breast cancer cells

por Wilke, Maria, Göbel, Andy, Rauner, Martina, Benad-Mehner, Peggy, Schütze, Norbert, Füssel, Susanne, Hadji, Peyman, Hofbauer, Lorenz C., Rachner, Tilman D.
Publicado 2014

Concurrent antitumor and bone-protective effects of everolimus in osteotropic breast cancer

por Browne, Andrew J., Kubasch, Marie L., Göbel, Andy, Hadji, Peyman, Chen, David, Rauner, Martina, Stölzel, Friedrich, Hofbauer, Lorenz C., Rachner, Tilman D.
Publicado 2017

Soluble Neuropilin-1 is an independent marker of poor prognosis in early breast cancer

por Rachner, Tilman D., Kasimir-Bauer, Sabine, Goebel, Andy, Erdmann, Kati, Hoffmann, Oliver, Rauner, Martina, Hofbauer, Lorenz C., Kimmig, Rainer, Bittner, Ann-Kathrin
Publicado 2021

Probenecid as a sensitizer of bisphosphonate-mediated effects in breast cancer cells

por Ebert, Regina, Meissner-Weigl, Jutta, Zeck, Sabine, Määttä, Jorma, Auriola, Seppo, Coimbra de Sousa, Sofia, Mentrup, Birgit, Graser, Stephanie, Rachner, Tilman D, Hofbauer, Lorenz C, Jakob, Franz
Publicado 2014

Plasma levels of Semaphorin 4D are decreased by adjuvant tamoxifen but not aromatase inhibitor therapy in breast cancer patients

por Göbel, Andy, Kuhlmann, Jan D., Link, Theresa, Wimberger, Pauline, Link-Rachner, Cornelia, Thiele, Stefanie, Dell'Endice, Stefania, Furesi, Giulia, Breining, Dorit, Rauner, Martina, Hofbauer, Lorenz C., Rachner, Tilman D.
Publicado 2019

High serum levels of Dickkopf-1 are associated with a poor prognosis in prostate cancer patients

por Rachner, Tilman D, Thiele, Stefanie, Göbel, Andy, Browne, Andrew, Fuessel, Susanne, Erdmann, Kati, Wirth, Manfred P, Fröhner, Michael, Todenhöfer, Tilman, Muders, Michael H, Kieslinger, Matthias, Rauner, Martina, Hofbauer, Lorenz C
Publicado 2014

Role of WNT5A receptors FZD5 and RYK in prostate cancer cells

por Thiele, Stefanie, Zimmer, Ariane, Göbel, Andy, Rachner, Tilman D., Rother, Sandra, Fuessel, Susanne, Froehner, Michael, Wirth, Manfred P., Muders, Michael H., Baretton, Gustavo B., Jakob, Franz, Rauner, Martina, Hofbauer, Lorenz C.
Publicado 2018